Author:
Baek Jong-Suep,Kim Bo-Sik,Puri Anu,Kumar K.,Cho Cheong-Weon
Funder
National Research Foundation of Korea
National Institutes of Health
Publisher
Springer Science and Business Media LLC
Subject
Organic Chemistry,Drug Discovery,Molecular Medicine
Reference39 articles.
1. Baek JS, Cho CW (2013) 2-Hydroxypropyl-β-cyclodextrin-modified SLN of paclitaxel for overcoming p-glycoprotein function in multidrug-resistant breast cancer cells. J Pharm Pharmacol 65:72–78
2. Baek JS, Shin SC, Cho CW (2012a) Effect of lipid on physicochemical properties of solid lipid nanoparticle of paclitaxel. J Pharm Investig 42:279–283
3. Baek JS, So JW, Shin SC, Cho CW (2012b) Solid lipid nanoparticles of paclitaxel strengthened by hydroxypropyl-β-cyclodextrin as an oral delivery system. Int J Mol Med 30:953–959
4. Baek JS, Kim JH, Park JS, Cho CW (2015) Modification of paclitaxel-loaded solid lipid nanoparticles with 2-hydroxypropyl-β-cyclodextrin enhances absorption and reduces nephrotoxicity associated with intravenous injection. Int J Nanomed 10:5397–5405
5. Cavalli R, Gasco MR, Chetoni P, Burqalassi S, Saettone MF (2002) Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin. Int J Pharm 238:241–245
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献